Pharma Deals Review, Vol 2005, No 57 (2005)

Font Size:  Small  Medium  Large

Antisoma Acquires Aptamera

Business Review Editor

Abstract


Antisoma acquired Aptamera in a share-based transaction initially valued at £11.5 M. Through the acquisition of Aptamera’s main asset, anticancer drug AGRO100, Antisoma expands its clinical portfolio.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.